GET THE APP

Probiotics: New prophylaxis and curing weapon against diseases
..

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Probiotics: New prophylaxis and curing weapon against diseases


2nd International Conference and Exhibition on Pharmaceutical Regulatory Affairs

November 23-24, 2012 Hyderabad International Convention Centre, India

Abhinandan Ravsaheb Patil

Accepted Abstracts: Pharmaceut Reg Affairs

Abstract :

Bacteria in this today world mostly considered as pathogenic. As every coin had two sides? bacteria though are pathogenic but still few are friendly essential for human growth and immunity. Such friendly bacteria are called Probiotics. L. acidophilus is one of probiotic bacterium found primarily in the small intestine where if introduced in sufficient colony serve as new prophylaxis and curing agent. Indian market lacks the quality uni-strain (containing one specific strain) product of the probiotics for the treatment and prophylaxis of the most of the disease. Commercially large use of antibiotics explored against the pathogenic micro-organism. By using the probiotics the hazardous of antibiotics can be minimized with the deletion of the side effects occurred due to heavy intake of xenobiotics drugs seen mostly in women?s and children as they are most sensitive and prone. The best mode to utilize healing quality of probiotics is to convert in dosage form. Technique require greater accuracy in case of the asepsis and maintenance of viability, This novel drug delivery system can also be beneficial for meeting the current needs with proper execution. Cfu (colony forming units) will give dry powder from culture media via process of encapsulation. To shape formulation capsule generation with unique dose adjustment will serve the Moto as new prophylaxis and curing agent against diseases even cancer. Inculcating the Onco (cancer cells) role is dramatically played by these wonder microbes by devising them in above described formulation.

Biography :

Abhinandan R Patil is now studying M.Pharma 2nd year at the age of 24 years from Shivaji University Maharashtra. He is the Pharma director of Atmatara foundation and working as junior scientist (Kolhapur: India). He has participated and won prizes in many national conferences.

Google Scholar citation report
Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

 
arrow_upward arrow_upward